nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparison of anticoagulation results of patients managed with narrow vs. standard international normalized ratio target ranges
|
MEIER, D. J. |
|
2007 |
5 |
6 |
p. 1332-1333 |
artikel |
2 |
A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor–glycoprotein Ib and integrin α2β1–collagen interactions make complementary, collagen-type-specific contributions to adhesion: a rebuttal
|
LISMAN, T. |
|
2007 |
5 |
6 |
p. 1338-1339 |
artikel |
3 |
A mechanism to safeguard platelet adhesion under high-shear flow: von Willebrand factor-glycoprotein Ib and integrin α2β1-collagen interactions make complementary, collagen-type-specific contributions to adhesion: reply to a rebuttal
|
MOROI, M. |
|
2007 |
5 |
6 |
p. 1340-1342 |
artikel |
4 |
ANNOUNCEMENTS
|
|
|
2007 |
5 |
6 |
p. 1344 |
artikel |
5 |
A novel anti-ischemic nitric oxide donor (LA419) reduces thrombogenesis in healthy human subjects
|
Zafar, M. U. |
|
2007 |
5 |
6 |
p. 1195-1200 |
artikel |
6 |
Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15-year longitudinal study
|
BIZZARO, N. |
|
2007 |
5 |
6 |
p. 1158-1164 |
artikel |
7 |
Antithrombotic and anticoagulant effects of the direct thrombin inhibitor dabigatran, and its oral prodrug, dabigatran etexilate, in a rabbit model of venous thrombosis
|
WIENEN, W. |
|
2007 |
5 |
6 |
p. 1237-1242 |
artikel |
8 |
Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay
|
ECKMANN, C. M. |
|
2007 |
5 |
6 |
p. 1330-1331 |
artikel |
9 |
Bleeding events and other complications during pregnancy and childbirth in women with von Willebrand disease
|
JAMES, A. H. |
|
2007 |
5 |
6 |
p. 1165-1169 |
artikel |
10 |
Calibration of the WHO 1st International Standard for blood coagulation factor V in plasma, human (03/116) 1
|
HUBBARD, A. R. |
|
2007 |
5 |
6 |
p. 1318-1319 |
artikel |
11 |
Complete inhibition of fibrinolysis by sustained carboxypeptidase B activity: the role and requirement of plasmin inhibitors
|
WALKER, J. B. |
|
2007 |
5 |
6 |
p. 1257-1264 |
artikel |
12 |
Continuous expression of Bcl-xL protein during megakaryopoiesis is post-translationally regulated by thrombopoietin-mediated Akt activation, which prevents the cleavage of Bcl-xL
|
KOZUMA, Y. |
|
2007 |
5 |
6 |
p. 1274-1282 |
artikel |
13 |
Corrigendum
|
|
|
2007 |
5 |
6 |
p. 1343 |
artikel |
14 |
Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials
|
DAVIDSON, B. L. |
|
2007 |
5 |
6 |
p. 1191-1194 |
artikel |
15 |
Effect of wine phenolics on cytokine-induced C-reactive protein expression
|
KAUR, G. |
|
2007 |
5 |
6 |
p. 1309-1317 |
artikel |
16 |
Efficient induction of immune tolerance to coagulation factor IX following direct intramuscular gene transfer
|
COHN, E. F. |
|
2007 |
5 |
6 |
p. 1227-1236 |
artikel |
17 |
Enhanced peripheral thrombogenicity after lung inflammation is mediated by platelet–leukocyte activation: role of P-selectin
|
NEMMAR, A. |
|
2007 |
5 |
6 |
p. 1217-1226 |
artikel |
18 |
Evidence of a U-shaped association between factor XII activity and overall survival
|
ENDLER, G. |
|
2007 |
5 |
6 |
p. 1143-1148 |
artikel |
19 |
Feasibility and accuracy of a rapid ‘point-of-care’ D-dimer test performed with a capillary blood sample
|
VAN DER VELDE, E. F. |
|
2007 |
5 |
6 |
p. 1327-1329 |
artikel |
20 |
Fibrinolysis in a lipid environment: modulation through release of free fatty acids
|
RÁBAI, G. |
|
2007 |
5 |
6 |
p. 1265-1273 |
artikel |
21 |
Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers
|
SABBÀ, C. |
|
2007 |
5 |
6 |
p. 1149-1157 |
artikel |
22 |
High risk for venous thromboembolism in diabetics with hyperosmolar state: comparison with other acute medical illnesses
|
KEENAN, C. R. |
|
2007 |
5 |
6 |
p. 1185-1190 |
artikel |
23 |
Increased plasmin-α2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses
|
BOUMA, B. |
|
2007 |
5 |
6 |
p. 1139-1142 |
artikel |
24 |
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study
|
ZAKAI, N. A. |
|
2007 |
5 |
6 |
p. 1128-1135 |
artikel |
25 |
Inflammatory/hemostatic biomarkers and cardiovascular risk: coming of age?
|
LOWE, G. D. O. |
|
2007 |
5 |
6 |
p. 1125-1127 |
artikel |
26 |
Left ventricular systolic dysfunction is an independent predictor of homocysteine in angiographically documented patients with or without coronary artery lesions
|
GUÉANT-RODRIGUEZ, R.-M. |
|
2007 |
5 |
6 |
p. 1209-1216 |
artikel |
27 |
Linkage analysis for three coagulation factors clustering on chromosome 13q34: factor VII, factor X and protein Z
|
VOSSEN, C. Y. |
|
2007 |
5 |
6 |
p. 1325-1326 |
artikel |
28 |
Local tissue-type plasminogen activator release in patients with ischemic stroke
|
JOOD, K. |
|
2007 |
5 |
6 |
p. 1320-1322 |
artikel |
29 |
Oxidative stress-mediated platelet CD40 ligand upregulation in patients with hypercholesterolemia: effect of atorvastatin
|
PIGNATELLI, P. |
|
2007 |
5 |
6 |
p. 1170-1178 |
artikel |
30 |
Polymorphism 10034C>T is located in a region regulating polyadenylation of FGG transcripts and influences the fibrinogen γ′/γA mRNA ratio
|
UITTE DE WILLIGE, S. |
|
2007 |
5 |
6 |
p. 1243-1249 |
artikel |
31 |
Postmenopausal oral estrogen therapy affects hemostatic factors, but does not account for reduction in the progression of subclinical atherosclerosis
|
VIGEN, C. |
|
2007 |
5 |
6 |
p. 1201-1208 |
artikel |
32 |
Role of elevated α2-macroglobulin revisited: results of a case-control study in children with symptomatic thromboembolism
|
BEHEIRI, A. |
|
2007 |
5 |
6 |
p. 1179-1184 |
artikel |
33 |
Thalidomide causes platelet activation, which can be abrogated by aspirin
|
DUNKLEY, S. |
|
2007 |
5 |
6 |
p. 1323-1324 |
artikel |
34 |
The bloody path of amyloids and prions
|
HAMMARSTRÖM, P. |
|
2007 |
5 |
6 |
p. 1136-1138 |
artikel |
35 |
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolysis rate: a rebuttal
|
WILLEMSE, J. L. |
|
2007 |
5 |
6 |
p. 1334-1336 |
artikel |
36 |
The intrinsic enzymatic activity of procarboxypeptidase U (TAFI) does not significantly influence the fibrinolytic rate: reply to a rebuttal
|
VALNICKOVA, Z. |
|
2007 |
5 |
6 |
p. 1336-1337 |
artikel |
37 |
The intrinsic pathway of coagulation: a target for treating thromboembolic disease?
|
GAILANI, D. |
|
2007 |
5 |
6 |
p. 1106-1112 |
artikel |
38 |
The relative kinetics of clotting and lysis provide a biochemical rationale for the correlation between elevated fibrinogen and cardiovascular disease
|
KIM, P. Y. |
|
2007 |
5 |
6 |
p. 1250-1256 |
artikel |
39 |
The suppressive effect of sphingosine 1-phosphate on monocyte-endothelium adhesion may be mediated by the rearrangement of the endothelial integrins α5β1 and αvβ3
|
AOKI, S. |
|
2007 |
5 |
6 |
p. 1292-1301 |
artikel |
40 |
The tissue factor–factor VIIa complex: procoagulant activity, regulation, and multitasking
|
MONROE, D. M. |
|
2007 |
5 |
6 |
p. 1097-1105 |
artikel |
41 |
The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells
|
DOU, L. |
|
2007 |
5 |
6 |
p. 1302-1308 |
artikel |
42 |
Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets
|
LOPEZ, J. J. |
|
2007 |
5 |
6 |
p. 1283-1291 |
artikel |
43 |
Treatment of severe von Willebrand disease with a high-purity von Willebrand factor concentrate (Wilfactin®): a prospective study of 50 patients
|
BOREL-DERLON, A. |
|
2007 |
5 |
6 |
p. 1115-1124 |
artikel |
44 |
von Willebrand disease: treatment with or without factor VIII?
|
KONKLE, B. A. |
|
2007 |
5 |
6 |
p. 1113-1114 |
artikel |